McCallum N, Najlah M
Cancers (Basel). 2024; 16(16).
PMID: 39199548
PMC: 11353049.
DOI: 10.3390/cancers16162775.
Robledo-Cadena D, Pacheco-Velazquez S, Vargas-Navarro J, Padilla-Flores J, Moreno-Sanchez R, Rodriguez-Enriquez S
Mini Rev Med Chem. 2024; 24(12):1187-1202.
PMID: 39004839
DOI: 10.2174/0113895575254320231030051124.
Liang X, Chen X, Yan Y, Cheng A, Lin J, Jiang Y
Acta Pharmacol Sin. 2024; 45(10):2011-2022.
PMID: 38811773
PMC: 11420344.
DOI: 10.1038/s41401-024-01304-w.
Shi Z, Hu C, Zheng X, Sun C, Li Q
Exp Hematol Oncol. 2024; 13(1):55.
PMID: 38778409
PMC: 11110349.
DOI: 10.1186/s40164-024-00519-1.
Barba I, Carrillo-Bosch L, Seoane J
Int J Mol Sci. 2024; 25(6).
PMID: 38542116
PMC: 10970388.
DOI: 10.3390/ijms25063142.
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.
Uo T, Ojo K, Sprenger C, Epilepsia K, Perera B, Damodarasamy M
Mol Cancer Ther. 2024; 23(7):973-994.
PMID: 38507737
PMC: 11219269.
DOI: 10.1158/1535-7163.MCT-23-0540.
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers.
Derouane F, Desgres M, Moroni C, Ambroise J, Berliere M, Van Bockstal M
Breast Cancer Res. 2024; 26(1):29.
PMID: 38374113
PMC: 10875828.
DOI: 10.1186/s13058-024-01788-8.
Expression and clinical significance of ECHS1 in gastric cancer.
Lu T, Sun L, Fan Q, Yan J, Zhao D, Xu C
J Cancer. 2024; 15(2):418-427.
PMID: 38169583
PMC: 10758025.
DOI: 10.7150/jca.88604.
Structure and Metabolically Oriented Efficacy of Fucoidan from Brown Alga in the Model of Colony Formation of Melanoma and Breast Cancer Cells.
Usoltseva R, Zueva A, Malyarenko O, Anastyuk S, Moiseenko O, Isakov V
Mar Drugs. 2023; 21(9).
PMID: 37755099
PMC: 10532595.
DOI: 10.3390/md21090486.
Metabolic aspects of genetic ion channel epilepsies.
Neal E, Xu W, Borges K
J Neurochem. 2023; 168(12):3911-3935.
PMID: 37594756
PMC: 11591411.
DOI: 10.1111/jnc.15938.
Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options.
Pourbaghi M, Haghani L, Zhao K, Karimi A, Marinelli B, Erinjeri J
Curr Oncol. 2023; 30(7):6609-6622.
PMID: 37504345
PMC: 10377758.
DOI: 10.3390/curroncol30070485.
Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E, Kuzmychova H, Senthil H, Kaul E, Chokshi C, Venugopal C
Acta Neuropathol Commun. 2023; 11(1):110.
PMID: 37420311
PMC: 10327182.
DOI: 10.1186/s40478-023-01604-y.
Glycemic Challenge Is Associated with the Rapid Cellular Activation of the Locus Ceruleus and Nucleus of Solitary Tract: Circumscribed Spatial Analysis of Phosphorylated MAP Kinase Immunoreactivity.
Tapia G, Agostinelli L, Chenausky S, Padilla J, Navarro V, Alagh A
J Clin Med. 2023; 12(7).
PMID: 37048567
PMC: 10095283.
DOI: 10.3390/jcm12072483.
Effects of metabolic cancer therapy on tumor microenvironment.
Hyrossova P, Milosevic M, Skoda J, Vachtenheim Jr J, Rohlena J, Rohlenova K
Front Oncol. 2022; 12:1046630.
PMID: 36582801
PMC: 9793001.
DOI: 10.3389/fonc.2022.1046630.
Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy.
Ji P, An B, Jie Z, Wang L, Qiu S, Ge C
Mater Today Bio. 2022; 18:100515.
PMID: 36582449
PMC: 9792908.
DOI: 10.1016/j.mtbio.2022.100515.
Biological Role and Mechanism of Lipid Metabolism Reprogramming Related Gene ECHS1 in Cancer.
Hu T, Chen X, Lu S, Zeng H, Guo L, Han Y
Technol Cancer Res Treat. 2022; 21:15330338221140655.
PMID: 36567598
PMC: 9806408.
DOI: 10.1177/15330338221140655.
Orchestration of mesenchymal plasticity and immune evasiveness rewiring of the metabolic program in pancreatic ductal adenocarcinoma.
Hashimoto A, Handa H, Hata S, Hashimoto S
Front Oncol. 2022; 12:1005566.
PMID: 36408139
PMC: 9669439.
DOI: 10.3389/fonc.2022.1005566.
Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer.
Choi S, Ribeiro C, Wang Y, Loda M, Plymate S, Uo T
Biomolecules. 2022; 12(11).
PMID: 36358940
PMC: 9687810.
DOI: 10.3390/biom12111590.
MYCN and Metabolic Reprogramming in Neuroblastoma.
Bansal M, Gupta A, Ding H
Cancers (Basel). 2022; 14(17).
PMID: 36077650
PMC: 9455056.
DOI: 10.3390/cancers14174113.
It's Not What You Take Up, It's What You Keep: How Discoveries from Diverse Disciplines Directed the Development of the FDG PET/CT Scan.
Kaunitz J, Mandelkern M, Fowler J
Dig Dis Sci. 2022; 67(10):4620-4632.
PMID: 35908123
DOI: 10.1007/s10620-022-07615-4.
